Strides Pharma’s subsidiary incorporates Pivot Path

Strides Pharma announced that Arco Lab Private, a wholly owned subsidiary of the company, has incorporated a new wholly owned subsidiary, Pivot Path Private Limited on April 10, 2025. 

Pivot Path will focus on life sciences and manufacturing solutions with its “deep domain knowledge and cutting-edge technology capabilities,” the company said.

[Read more: Strides Pharma receives FDA nod for generic Renvela]

Pivot Path is in the business of outsourcing and business support services for all processes, sub-processes, transactions, activities and all other work performed in various industries with a specific emphasis on the pharmaceutical sector, within India and worldwide.

[Read more: Strides Pharma announces completion of Bharat Dhirajlal Shah’s tenure as independent director]